Lupin launches Minocycline Hydrochloride extended release tablets in US Farhat Nasim27 Feb 2019 9:40 AM ISTThe company has launched Minocycline Hydrochloride extended-release tablets USP in the strength of 55 mg, after receiving approval from the United...
Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation Farhat Nasim26 Feb 2019 9:50 AM ISTThe company has received approval from the US Food and Drug Administration (USFDA) to market Methylprednisolone tablets, a generic version of...
USFDA completes audit for Dr Reddys Shreveport plant, no observations issued Medical Dialogues Bureau23 Feb 2019 9:30 AM IST"The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
Mylan launches Advair generic at 70 percent discount in US Farhat Nasim14 Feb 2019 9:15 AM ISTThe treatment, the first generic of Advair, is approved in three doses and will be priced between $93.71 and $153.14, the company said.U.S: Mylan NV...
Glenmark gets tentative USFDA nod to breast cancer injection Fulvestrant Farhat Nasim8 Feb 2019 11:40 AM ISTFulvestrant injection is a generic version of AstraZeneca Pharmaceuticals LP's Faslodex injection in the same strength, it added. The Faslodex...
Cancer Causing Asbestos Threat: Sri Lanka halts imports of Johnson & Johnson Baby Powder Medical Dialogues Bureau1 Feb 2019 12:51 PM ISTCOLOMBO (Reuters) - Sri Lanka has halted imports of Johnson & Johnson Baby Powder until the company proves its product is free from cancer-causing...
Reckitt Benckiser chief Rakesh Kapoor to step down Farhat Nasim18 Jan 2019 9:00 AM ISTOne of UK's highest-paid CEOs Rakesh Kapoor will leave Reckitt Benckiser by end of 2019.New Delhi: British FMCG major Reckitt Benckiser (RB) Wednesday...
Lupin gets USFDA nod for generic schizophrenia drug Medical Dialogues Bureau8 Jan 2019 12:10 PM ISTNew Delhi: Drug maker Lupin Monday said it has received approval from the US health regulator to market Lurasidone Hydrochloride tablets, used in the...
Pfizer lowers revenue forecast on strong dollar, supply issues Medical Dialogues Bureau31 Oct 2018 5:15 PM ISTU.S. drugmaker Pfizer Inc cut the top end of its full-year revenue forecast range on Tuesday, citing a stronger dollar and lower revenue from its...
Hetero Labs recalls over 15.90 lakh bottles of hypertension drug from US Ruby Khatun Khatun30 Aug 2018 11:26 AM ISTNew Delhi: Drug firm Hetero Labs is recalling over 15.90 lakh bottles of Valsartan Tablets used for the treatment of hypertension from the American...
US court upholds dismissal of 200 million dollars Merck verdict against Gilead Ruby Khatun Khatun27 April 2018 9:30 AM ISTA U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
DRL recalls 80,000 plus bottles of Atorvastatin from US due to quality concerns Medical Dialogues Bureau9 Feb 2018 11:28 AM ISTHYDERABAD: Dr. Reddy's Laboratories has initiated a voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and...
